World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
163
Citations
95639
World Ranking
689
National Ranking
397

Overview

Michael Andreeff is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on the fields of medicine and biochemistry, genetics, and molecular biology, with a strong emphasis on hematology and molecular biology subfields. The scientist's work spans oncology, genetics, and cancer research, addressing various complex aspects of malignant diseases.

Their contributions are notably concentrated in areas such as acute myeloid leukemia, protein degradation and inhibitors, chronic myeloid leukemia treatments, multiple myeloma research and treatments, histone deacetylase inhibitors research, myeloproliferative neoplasms diagnosis and treatment, and chronic lymphocytic leukemia research.

Prominent recent publications include:

  • Bone marrow niches in haematological malignancies, 2020, Nature reviews. Cancer
  • MDM2 inhibition: an important step forward in cancer therapy, 2020, Leukemia
  • Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics, 2020, Nature Communications
  • Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia, 2021, Journal of Clinical Oncology
  • 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial, 2020, The Lancet Haematology

The scientist frequently collaborates with several researchers in the field, including:

  • Marina Konopleva
  • Courtney D. DiNardo
  • Elias Jabbour
  • Guillermo Garcia-Manero
  • Hagop M. Kantarjian

Among the journals where Michael Andreeff has published, the most frequent venues are Blood, Clinical Lymphoma Myeloma & Leukemia, Cancer Research, Leukemia, and Juntendo Medical Journal. These venues reflect a consistent focus on hematology, oncology, and related clinical research.

Best Publications

  • Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).

    Raymond P. Warrell;Stanley R. Frankel;Wilson H. Miller;David A. Scheinberg

  • Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas

    Akira Nakamizo;Frank Marini;Toshiyuki Amano;Asadullah Khan

  • Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

    Michael J. Keating;Susan O'Brien;Maher Albitar;Susan Lerner

  • Bone Marrow-derived Mesenchymal Stem Cells as Vehicles for Interferon-β Delivery into Tumors

    Matus Studeny;Frank C. Marini;Richard E. Champlin;Claudia Zompetta

  • Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

    Marina Konopleva;Rooha Contractor;Twee Tsao;Ismael Samudio

  • Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents

    Matus Studeny;Frank C. Marini;Jennifer L. Dembinski;Claudia Zompetta

  • MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

    Ramiro Garzon;Shujun Liu;Muller Fabbri;Zhongfa Liu

  • Flow Cytometry in Clinical Cancer Research

    Barthel Barlogie;Martin N. Raber;Johannes Schumann;Tod S. Johnson

  • Expression and Prognostic Significance of IAP-Family Genes in Human Cancers and Myeloid Leukemias

    Ingo Tamm;Steven M. Kornblau;Harry Segall;Stanislaw Krajewski

  • Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression

    Erika L. Spaeth;Jennifer L. Dembinski;A Kate Sasser;Keri B. Watson

  • Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

    Hagop M Kantarjian;Susan O'Brien;Terry L. Smith;Jorge E Cortes

  • Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

    Sergio Giralt;Peter F. Thall;Issa Khouri;Xuemei Wang

  • MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

    Ramiro Garzon;Stefano Volinia;Stefano Volinia;Chang-Gong Liu;Cecilia Fernandez-Cymering

  • Cancer stem cell definitions and terminology: the devil is in the details

    Peter Valent;Dominique Bonnet;Ruggero De Maria;Tsvee Lapidot

  • Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

    Raoul Tibes;Yi Hua Qiu;Yiling Lu;Bryan Hennessy

  • Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging.

    Shannon Kidd;Erika Spaeth;Jennifer L. Dembinski;Martin Dietrich

  • Convention on nomenclature for DNA cytometry

    Wolfgang Hiddemann;Johannes Schumann;Michael Andreeff;Barthel Barlogie

  • Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

    Ismael Samudio;Romain Harmancey;Michael Fiegl;Hagop Kantarjian

  • Treatment of Philadelphia chromosome–positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

    Deborah A. Thomas;Stefan Faderl;Jorge Cortes;Susan O'Brien

  • Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells

    E. Spaeth;Ann H Klopp;J. Dembinski;Michael Andreeff

Frequent Co-Authors

Marina Konopleva
Marina Konopleva The University of Texas MD Anderson Cancer Center
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Jorge E. Cortes
Jorge E. Cortes Augusta University
Steven M. Kornblau
Steven M. Kornblau The University of Texas MD Anderson Cancer Center
Gautam Borthakur
Gautam Borthakur The University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero
Guillermo Garcia-Manero The University of Texas MD Anderson Cancer Center
Farhad Ravandi
Farhad Ravandi The University of Texas MD Anderson Cancer Center
Naval Daver
Naval Daver The University of Texas MD Anderson Cancer Center
Elias Jabbour
Elias Jabbour The University of Texas MD Anderson Cancer Center
Sherry Pierce
Sherry Pierce The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking flexible study options or alternative career paths, there are many online degrees to consider. One popular choice is becoming a psychiatric nurse practitioner. There are psych np programs available online, letting you specialize in mental health treatment while balancing work or family commitments.

If you’re more interested in healthcare operations and leadership, a health administration degree online can train you in management skills needed to run clinics, hospitals, and health organizations. For those looking to upskill further, pursuing a postgraduate business-focused qualification is an option. Learn about masters in healthcare administration cost to find affordable ways to advance your career.

Advanced practice nurses may want to consider a Doctor of Nursing Practice. There are cheap dnp online programs for those seeking to reach the highest levels of clinical expertise and leadership in healthcare without overwhelming tuition costs.

Best Scientists Citing Michael Andreeff

Trending Scientists

Recently Published Articles